Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial. - Edupuganti S; Hurt CB; Stephenson KE; Huang Y; Paez CA; Yu C; Yen C; Hanscom B; He Z; Miner MD; Gamble T; Heptinstall J; et al. (The lancet. HIV, 2025)